CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: In conclusion, the original procedure used to evaluate the intracellular accumulation of nilotinib allowed us to detect nilotinib in mature PMN and CD34+ cell subsets of the primary CP-CML clone in standardized conditions.